(AP Photo/Allen G. Breed, File)

The U.S. Supreme Court on Thursday unanimously rejected a lawsuit challenging the federal Food and Drug Administration's loosening of restrictions on the common abortion drug mifepristone, holding that a group of anti-abortion doctors lacks legal standing to bring the challenge.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Jimmy Hoover

Jimmy Hoover covers the Supreme Court for The National Law Journal. He can be reached at [email protected]. Follow him on Twitter: @JimmyHooverDC.